|
Christopher J. Sweeney, MBBS, is Assistant Professor in the Department of Medicine with appointments in Hematology-Oncology and Clinical Pharmacology. He received his medical degrees from the University of Adelaide, South Australia in 1992, and completed an internship at the Royal Adelaide Hospital. From 1994 to 1997, Dr. Sweeney was an Internal Medicine resident at Gundersen Lutheran Medical Center, La Crosse, Wisconsin, and from 1997 to 2000, he was a Fellow in Hematology/Oncology at Indiana University Medical Center. Dr. Sweeney is certified by the American Board of Internal Medicine in Internal Medicine and Medical Oncology. He is a member of several professional societies, including the American Society of Clinical Oncology, Eastern Cooperative Oncology Group, and American Association for Cancer Research. He has authored and co-authored several articles and abstracts in peer-reviewed journals, as well as several monographs and book chapters. He has focused his academic career at cancer drug development by performing
- phase I dose escalation trials with pharmacokinetic and pharmacodynamic endpoints
- phase I trials of new chemotherapeutics in patients with renal dysfunction
- pharmacogenomic and biomarker discovery studies
- trials of targeted therapies and
- drug discovery in the laboratory.
Dr. Sweeney is the Clinical Director of the Developmental Therapeutics Program in the Division of Hematology-Oncology. Dr. Sweeney also currently serves on the Cancer Education Committee of the American Society of Clinical Oncology. He has peer reviewed funding from the PhRMA Foundation (Faculty Development Award), the National Institutes of Health and the Department of Defense.
|
